Status:
COMPLETED
Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
Odense University Hospital
Sygehus Lillebaelt
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The primary study, as outlined in the original trial registration, aiming to use ultrasound speckle tracking (STU) to monitor muscle contractility in multiple sclerosis (MS) patients receiving vs. not...
Detailed Description
The primary study, as outlined in the original trial registration, aiming to use ultrasound speckle tracking (STU) to monitor muscle contractility in multiple sclerosis (MS) patients receiving vs. not...
Eligibility Criteria
Inclusion
- Fills the criteria for fampridine treatment
- Fills the diagnostic McDonald criteria for MS
- Age between 18 and 100 years
- EDSS between 4 and 7
Exclusion
- Diagnosed epilepsy
- MS attack or an acute decrease of functional capacity within the last 60 days
- Change in immunomodulatory treatment within the last 60 days
- Cancer within the last 5 years
- Clinically significant systemic disease
- Concurrent treatment with cimetidine, carvediol, propanolol and metformine
Key Trial Info
Start Date :
December 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03847545
Start Date
December 12 2018
End Date
October 15 2021
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern Denmark - Odense Univarsity Hospital
Odense C, Denmark, 5000